Literature DB >> 17051350

A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene.

M Vernez1, P Hutter, C Monnerat, N Halkic, O Gugerli, H Bouzourene.   

Abstract

Muir-Torre syndrome (MTS) is a rare cancer-predisposing syndrome that is autosomal dominantly inherited and characterized by the development of sebaceous skin lesions (adenomas, epitheliomas, basaliomas and carcinomas). These lesions are typically associated with tumors that belong to the spectrum of hereditary nonpolyposis colorectal cancer (HNPCC) (i.e., tumors of the colorectum, endometrium, stomach or ovary). Biliary malignancy in association with MTS has only rarely been reported. We report a case of Muir-Torre syndrome associated with intrahepatic cholangiocarcinoma, a location not previously described, and associated with a novel missense mutation of the MSH2 gene (c.2026T > C), predicted to disrupt the function of the gene.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17051350     DOI: 10.1007/s10689-006-9105-9

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  14 in total

1.  Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis.

Authors:  M Pedroni; E Sala; A Scarselli; F Borghi; M Menigatti; P Benatti; A Percesepe; G Rossi; M Foroni; L Losi; C Di Gregorio; A De Pol; R Nascimbeni; E Di Betta; B Salerni; M P de Leon; L Roncucci
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

2.  The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinoma.

Authors:  J P Mecklin; H J Järvinen; M Virolainen
Journal:  Cancer       Date:  1992-03-01       Impact factor: 6.860

3.  A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome.

Authors:  E Mangold; C Pagenstecher; M Leister; M Mathiak; A Rütten; W Friedl; P Propping; T Ruzicka; R Kruse
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

4.  Mucin-producing cholangiocarcinoma: clinical experience of 24 cases in 16 years.

Authors:  Chung-Mou Kuo; Chi-Sin Changchien; Keng-Liang Wu; Seng-Kee Chuah; King-Wah Chiu; Yi-Chun Chiu; Yeh-Pin Chou; Chung-Huang Kuo
Journal:  Scand J Gastroenterol       Date:  2005-04       Impact factor: 2.423

5.  Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations.

Authors:  G Ponti; M Ponz de Leon; S Maffei; M Pedroni; L Losi; C Di Gregorio; V Gismondi; A Scarselli; P Benatti; B Roncari; S Seidenari; G Pellacani; C Varotti; E Prete; L Varesco; L Roncucci
Journal:  Clin Genet       Date:  2005-11       Impact factor: 4.438

6.  Multiple sebaceous tumors.

Authors:  D Torre
Journal:  Arch Dermatol       Date:  1968-11

Review 7.  The tumor spectrum in the Lynch syndrome.

Authors:  Patrice Watson; Bronson Riley
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

8.  Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face.

Authors:  E G Muir; A J Bell; K A Barlow
Journal:  Br J Surg       Date:  1967-03       Impact factor: 6.939

Review 9.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

10.  Microsatellite instability in Muir-Torre syndrome.

Authors:  R Honchel; K C Halling; D J Schaid; M Pittelkow; S N Thibodeau
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

View more
  6 in total

1.  The liver: another organ involved in Muir Torre syndrome?

Authors:  F Morando; M Alaibac; A Romano; M Cavallin; S Piano; M Pizzi; C Mescoli; P Pilati; A Gatta; P Angeli
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

2.  Muir-Torre syndrome associated with endometrial carcinoma.

Authors:  Toshimitsu Tohya; Takeshi Ogura; Kengo Nishi; Hazuki Nishi; Kazumi Kuriwaki
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

3.  Hereditary pancreatic and hepatobiliary cancers.

Authors:  Ashraf Haddad; Gopal C Kowdley; Timothy M Pawlik; Steven C Cunningham
Journal:  Int J Surg Oncol       Date:  2011-06-28

4.  Different responses to anti-programmed cell death protein 1 (PD-1) immunotherapy in a patient with Lynch syndrome and metachronous urothelial and colon cancer: A case report.

Authors:  Yu Feng; Yufeng Cao; Mingming Yuan; Rongrong Chen; Xue Ji; Xingsheng Hu
Journal:  Oncol Lett       Date:  2019-09-23       Impact factor: 2.967

5.  Thyroid cancer in a patient with a germline MSH2 mutation. Case report and review of the Lynch syndrome expanding tumour spectrum.

Authors:  Rein P Stulp; Johanna C Herkert; Arend Karrenbeld; Bart Mol; Yvonne J Vos; Rolf H Sijmons
Journal:  Hered Cancer Clin Pract       Date:  2008-02-15       Impact factor: 2.857

Review 6.  Mucinous cholangiocarcinoma: Clinicopathological features of the rarest type of cholangiocarcinoma.

Authors:  Tatsuaki Sumiyoshi; Yasuo Shima; Takehiro Okabayashi; Ayako Ishikawa; Manabu Matsumoto; Jun Iwata; Sojiro Morita; Taijiro Sueda
Journal:  Ann Gastroenterol Surg       Date:  2017-06-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.